Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Optical 76
Immune Disorders Drugs 74
Optical Disorders Drugs 66
Cardiovascular Drugs 42
Musculoskeletal Disorders Drugs 38
Dermatological Drugs 37
Drug Discovery 36
Biopharmaceuticals 36
Biotechnology 33
Genomics 27
Clinical Trials 19
Endocrine and Metabolic Disorders Drugs 19
Allergy and Immunology 18
Central Nervous System Drugs 18
Pharmaceuticals 18
Skin Cancer Drugs 18
Infectious Diseases Drugs 16
Drugs by Therapeutic Area 14
Respiratory Drugs 14
Infusions and Injectables 13
Allergy Drugs 13
Lung Cancer Drugs 12
Dermatology 10
Gastrointestinal Drugs 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Diagnostics 7
Needles and Syringes 7
Enzymes 6
Vaccines 6
Biosimilars and Biosuperiors 6
Asthma Drugs 6
Pharmaceutical Manufacturing 6
Prostate Cancer Drugs 5
Drug Delivery 5
Gastroenterology 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Immunosuppressive Drugs 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Lymphoma Drugs 3
Colon Cancer Drugs 3
Brain Cancer Drugs 3
Cardiovascular Devices 3
Analgesics 3
Medical Devices 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Neurology 2
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Cardiology 2
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Palliative Care 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

652 Results (Page 12 of 33)
- Relevance
  Sort by

Atopic Eczema Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
87 Pages
Global

From

€3500EUR$4,248USD£3,128GBP

Age-related Macular Degeneration (AMD) - Market Insight, Epidemiology And Market Forecast - 2032

 Report
June 2022
320 Pages
Global

From

€12270EUR$13,900USD£10,595GBP

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

 Report
October 2021
78 Pages
Global

From

€706EUR$800USD£610GBP

Ophthalmic Drugs Market Report 2026-2036

 Report
February 2026
393 Pages
Global

From

€5214EUR$6,113USD£4,350GBP

Mammalian Cell Fermentation Technology Market Size, Share & Trends Analysis Report By Type, By Application (Monoclonal Antibodies, Recombinant Proteins), By End-use, By Region, And Segment Forecasts, 2023 - 2030

 Report
May 2023
180 Pages
Global

From

€5252EUR$5,950USD£4,535GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1036 Pages
Global

From

€2207EUR$2,500USD£1,906GBP

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
138 Pages
Global

From

€1765EUR$2,000USD£1,525GBP

Biobetters - Global Strategic Business Report

 Report
May 2026
488 Pages
Global

From

€5164EUR$5,850USD£4,459GBP

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
2271 Pages
Global

From

€2207EUR$2,500USD£1,906GBP

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2207EUR$2,500USD£1,906GBP

Inhalable Drugs - Global Strategic Business Report

 Report
May 2026
270 Pages
Global

From

€5164EUR$5,850USD£4,459GBP

Bullous Pemphigoid - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€6620EUR$7,500USD£5,717GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1765EUR$2,000USD£1,525GBP

Allergic Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
180 Pages
Global

From

€1765EUR$2,000USD£1,525GBP

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

 Report
June 2025
150 Pages
Global

From

€5252EUR$5,950USD£4,535GBP

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1182 Pages
Global

From

€2207EUR$2,500USD£1,906GBP

Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

 Report
July 2023
229 Pages
Global

From

€3178EUR$3,600USD£2,744GBP

Leukemia Therapeutics - Global Strategic Business Report

 Report
May 2026
193 Pages
Global

From

€5164EUR$5,850USD£4,459GBP

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
820 Pages
Global

From

€1765EUR$2,000USD£1,525GBP

Aflibercept Market - Global Forecast 2025-2032

 Report
November 2025
181 Pages
Global

From

€3129EUR$3,545USD£2,702GBP

€3477EUR$3,939USD£3,003GBP

652 Results (Page 12 of 33)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.